Puma Biotechnology
PBYI
PBYI
188 hedge funds and large institutions have $5.13B invested in Puma Biotechnology in 2014 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 76 increasing their positions, 54 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.47% more ownership
Funds ownership: 88.59% → 90.06% (+1.5%)
19% less capital invested
Capital invested by funds: $6.36B → $5.13B (-$1.23B)
28% less call options, than puts
Call options by funds: $33M | Put options by funds: $45.6M
Holders
188
Holding in Top 10
5
Calls
$33M
Puts
$45.6M
Top Buyers
| 1 | +$236M | |
| 2 | +$95.3M | |
| 3 | +$36.2M | |
| 4 |
CCI
Columbus Circle Investors
|
+$21.9M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$20.7M |
Top Sellers
| 1 | -$146M | |
| 2 | -$80.9M | |
| 3 | -$60.5M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$54.4M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$34.9M |